TY - JOUR
T1 - Readmission after robot-assisted radical cystectomy
T2 - Outcomes and predictors at 90-day follow-up
AU - Al-Daghmin, Ali
AU - Aboumohamed, Ahmed
AU - Din, Rakeeba
AU - Khan, Aabroo
AU - Raza, Syed Johar
AU - Sztorc, Jenna
AU - Mehedint, Diana
AU - Sharif, Mohammad
AU - Shi, Yi
AU - Wilding, Gregory
AU - Guru, Khurshid A.
PY - 2014/2
Y1 - 2014/2
N2 - Objective To characterize the outcomes and predictors of readmission after robot-assisted radical cystectomy (RARC) during early (30-day) and late (31-90-day) postoperative periods. Methods We retrospectively evaluated our prospectively maintained RARC quality assurance database of 272 consecutive patients operated between 2005 and 2012. We evaluated the relationship of readmission with perioperative outcomes and examined possible predictors during the postoperative period. Results Overall 30- and 90-day mortality was 0.7% and 4.8%, respectively, with 25.5% patients readmitted within 90 days after RARC (61% of them were readmitted within 30 days and 39% were readmitted between 31-90 days postoperatively). Infection-related problems were the most common cause of readmission during early and late periods. Overall operative time and obesity were significantly associated with readmission (P =.034 and.033, respectively). Body mass index and female gender were independent predictors of 90-day readmission (P =.004 and.014, respectively). Having any type of complication correlated with 90-day readmission (P =.0045); meanwhile, when complications were graded on the basis of Clavien grading system, only grade 1-2 complications statistically correlated with readmission (P =.046). Four patients needed reoperation (2 patients in early "for appendicitis and adhesive small bowel obstruction" and 2 in late "for ureteroenteric stricture" readmission); meanwhile, 6 patients needed percutaneous procedures (4 patients in early "1 for anastomotic leak and 3 for pelvic collections" and 2 "for pelvic collections and ureterocutaneous fistula" in late readmission). Conclusion The rate of readmission within 90 days after RARC is significant. Female gender and body mass index are independent predictors of readmission. Outcomes at 90 days provide more thorough results, essential to proper patient counseling.
AB - Objective To characterize the outcomes and predictors of readmission after robot-assisted radical cystectomy (RARC) during early (30-day) and late (31-90-day) postoperative periods. Methods We retrospectively evaluated our prospectively maintained RARC quality assurance database of 272 consecutive patients operated between 2005 and 2012. We evaluated the relationship of readmission with perioperative outcomes and examined possible predictors during the postoperative period. Results Overall 30- and 90-day mortality was 0.7% and 4.8%, respectively, with 25.5% patients readmitted within 90 days after RARC (61% of them were readmitted within 30 days and 39% were readmitted between 31-90 days postoperatively). Infection-related problems were the most common cause of readmission during early and late periods. Overall operative time and obesity were significantly associated with readmission (P =.034 and.033, respectively). Body mass index and female gender were independent predictors of 90-day readmission (P =.004 and.014, respectively). Having any type of complication correlated with 90-day readmission (P =.0045); meanwhile, when complications were graded on the basis of Clavien grading system, only grade 1-2 complications statistically correlated with readmission (P =.046). Four patients needed reoperation (2 patients in early "for appendicitis and adhesive small bowel obstruction" and 2 in late "for ureteroenteric stricture" readmission); meanwhile, 6 patients needed percutaneous procedures (4 patients in early "1 for anastomotic leak and 3 for pelvic collections" and 2 "for pelvic collections and ureterocutaneous fistula" in late readmission). Conclusion The rate of readmission within 90 days after RARC is significant. Female gender and body mass index are independent predictors of readmission. Outcomes at 90 days provide more thorough results, essential to proper patient counseling.
UR - http://www.scopus.com/inward/record.url?scp=84893182549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893182549&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2013.09.056
DO - 10.1016/j.urology.2013.09.056
M3 - Article
C2 - 24468509
AN - SCOPUS:84893182549
SN - 0090-4295
VL - 83
SP - 350
EP - 356
JO - Urology
JF - Urology
IS - 2
ER -